Until now, studies of postcoid syndrome have been carried out mainly among patients with severe or moderate course of the disease. In January, Wuhan scientists published the results of a six-month follow-up of 1,733 people hospitalized with COVID-19 during the first outbreak in early 2020. Six months after discharge, 76% of patients reported at least one symptom six months later. Most often, those who had been ill complained of increased fatigue and muscle weakness – 63%. Sleep problems and symptoms of anxiety and depression were reported by 26% of the participants.
A new study from the University of Washington, Seattle, for the first time assessed the long-term effects of COVID-19 in outpatients. Scientists shared the results of observations of 177 participants, of whom 150 had a mild infection, 16 had a moderate or severe course, and 11 were asymptomatic carriers of SARS-Cov-2.
More than 30% of study participants reported worsening quality of life after COVID-19. Most often, the respondents complained of fatigue (13.6%) and loss of smell and taste (13.6%). Another 14 people, including 9 participants who had a mild course of the infection, reported difficulty doing daily activities.
“Given the number of cases worldwide, continued weakness in some patients could have enormous health and economic implications,” the study authors wrote.
According to the Johns Hopkins University tracker, more than 110.7 million cases of COVID-19 have been reported worldwide to date, and over 2.4 million people have died.